A revolution is underway in the world of medicine—one driven by the extraordinary potential of stem cells.
In Episode 7: Stem Cell Revolution – Homologous Schmologous, experts dive deep into the science, regulatory challenges, and ethical debates surrounding stem cell therapy.
The episode breaks down complex concepts such as homologous vs. non-homologous use, minimal manipulation, and the FDA’s role in overseeing these groundbreaking treatments.
The conversation reveals how current regulations impact patients, researchers, and manufacturers, raising critical questions about access to regenerative therapies.
From bone marrow transplants to PRP injections, the episode explores how these treatments work, where they fall within regulatory frameworks, and why some therapies face stricter scrutiny than others.
Whether you’re a scientist, a patient seeking cutting-edge treatments, or simply curious about the future of medicine, this episode offers invaluable insights into the evolving landscape of regenerative medicine.
Watch now to explore the opportunities and challenges shaping the next frontier of healthcare.